Relating to: modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)
Failed to pass pursuant to Senate Joint Resolution 1
Email me when SB 1047 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 1047. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would make Wisconsin’s reimbursement for substance‑use disorder treatment with opioid medications match state‑adjusted Medicare rates starting in 2027. It also rewrites many rules for opioid treatment programs, covering who can practice, staffing ratios, patient admission criteria, dosing limits, and take‑home medication requirements. The changes aim to standardize care, improve oversight, and ensure consistent payment for services.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 1047
3 free questions a day, no accountHistory
- Failed to pass pursuant to Senate Joint Resolution 1
- Public hearing held
- Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families
- Introduced by Senators Testin, James and Wanggaard; cosponsored by Representatives Kurtz, Dittrich, Duchow, Knodl, Maxey, Moses, Mursau, Nedweski, Novak, O'Connor, Rodriguez, Snodgrass and Steffen
Sponsors
- Testin · sponsor
- James
- Wanggaard
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 1047 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 1047 freeOr ask your AI assistant about SB 1047 directly:
Add to Claude, ChatGPT or Cursor